ALB

Albemarle (ALB) closed at $93.67, up 1.22% and outperforming the S&P 500's 0.52% decline. The specialty chemicals company is expected to report earnings on November 4, 2026, with projected EPS of $2.39 (up 1357.89% YoY) and revenue of $1.49 billion (up 14.15% YoY).

However, the stock holds a Zacks Rank #3 (Hold) with a recent 1.79% downward revision in consensus EPS estimates. Trading at a Forward P/E of 8.27 and PEG ratio of 0.55, ALB appears undervalued relative to its industry, though the Chemical - Diversified sector ranks in the bottom 19% of industries.

Albemarle stock declined 2.84% to $95.39, outpacing the broader market's 1.09% loss. The specialty chemicals company has lost 14.66% over the past month, significantly underperforming the S&P 500's 2.44% gain.

Upcoming earnings on November 4, 2026 are expected to show strong growth with EPS projected at $2.44 (up 1384.21% YoY) and revenue of $1.49 billion (up 14.15% YoY). However, the stock carries a Zacks Rank #3 (Hold) rating with a recent 0.83% downward revision in consensus EPS estimates.

Albemarle Corporation (ALB) has declined 14.4% over the past month, underperforming the S&P 500. The company received a Zacks Rank #5 (Strong Sell) rating due to negative earnings estimate revisions (-24.9% over 30 days for current quarter), despite strong recent financial performance with revenue growth of 31.1% and EPS surprise of 11.94%. The stock is trading at par valuation with peers but is expected to underperform the broader market in the near term.

Robinhood Markets (HOOD) was named Bull of the Day after posting strong Q2 earnings and expanding its business lines to 13 revenue-generating units, earning a Zacks Rank #1 (Strong Buy). The stock has dropped 30% from October 2025 peaks but offers 25% upside potential. Conversely, Albemarle Corporation (ALB) was named Bear of the Day as the world's largest lithium producer faces headwinds from tanking lithium prices (down 80% from late 2022 highs), slowing EV sales, and increased supply, earning a Zacks Rank #5 (Strong Sell) after downward earnings revisions.

Albemarle Corporation (ALB), the world's largest lithium producer, has received a Zacks Rank #5 (Strong Sell) rating due to significant downward earnings revisions. Lithium prices have plummeted ~80% from late 2022 peaks as EV sales growth has slowed and lithium supply has increased.

The company's Q3 earnings outlook dropped 13% and Q4 dropped 36% following disappointing Q2 guidance. ALB stock is down 55% over five years while the S&P 500 surged 85%.

Albemarle (ALB) closed at $98.51, down 2.73% from the previous day, underperforming the S&P 500. The stock has declined 13.83% over the past month.

Despite strong earnings growth projections for Q3 2026 (EPS of $2.44, up 1384.21% YoY) and full-year estimates, the company holds a Zacks Rank of #5 (Strong Sell) with a downward EPS estimate revision of 1.27% over the past month. The stock trades at a Forward P/E of 9.01, below its industry average of 15.34.

Albemarle closed at $106.35, up 1.9% and outpacing the S&P 500's 0.58% gain. However, the stock has declined 17.35% over the past month, underperforming the Basic Materials sector.

The company is scheduled to report earnings on November 4, 2026, with analysts expecting significant year-over-year growth in EPS and revenue. Albemarle currently holds a Zacks Rank of #4 (Sell) with a Forward P/E ratio of 9.18, trading at a discount to its industry average.

Albemarle Corporation paid down $1.3 billion in debt in March 2026, reducing annual interest expenses by $60 million. The company ended Q2 with $1.88 billion in long-term debt and a net debt-to-EBITDA ratio of 0.5x, with $3.2 billion in liquidity and no major debt maturities until late 2028. The deleveraging efforts are expected to improve financial flexibility and reduce interest costs to $120-$140 million for 2026.

Albemarle (ALB) declined 1.71% to $105.78, underperforming the S&P 500's 0.25% loss. The specialty chemicals company has fallen 20.6% over the past month, significantly worse than its sector's 8.47% decline.

Despite strong earnings forecasts showing 1442% EPS growth and 16% revenue growth for the upcoming quarter, ALB holds a Zacks Rank #4 (Sell) rating. The stock trades at a Forward P/E of 9.45, below its industry average of 15.9, with a PEG ratio of 0.63 suggesting undervaluation.

Albemarle (ALB) has declined 20.6% over the past month, significantly underperforming the S&P 500. While the company shows strong revenue growth (+18.7% projected for current fiscal year) and has consistently beaten earnings and revenue estimates, it received a Zacks Rank #4 (Sell) rating due to unchanged earnings estimate revisions. The stock trades at a valuation discount to peers but is expected to underperform the broader market in the near term.

Albemarle (ALB) and Rio Tinto (RIO) are both well-positioned to benefit from growing lithium demand driven by electric vehicles and energy storage. ALB is executing capacity expansion projects and achieving significant cost savings, while RIO is advancing major lithium projects with a stronger balance sheet. Rio Tinto appears to offer better value with more attractive valuation metrics, higher return on equity, and rising earnings estimates, making it the more favorable investment option currently.

The global microporous materials market is projected to grow from $5.9 billion in 2024 to $7.2 billion by 2030, expanding at a 3.2% CAGR. Growth is driven by rising demand for carbon capture, clean fuels, purification, and advanced manufacturing applications.

Key players including BASF, Honeywell UOP, Albemarle, and Evonik are accelerating development of metal-organic frameworks (MOFs) and carbon-capture technologies. Asia-Pacific, particularly China, is expected to see strong growth at 5.8% CAGR.